Pentagon Backs Neutron With $150M Loan as Q4 Loss Outlook Disappoints
RKLB sits 72% above its 52-week low of $37.57.
Summary
Rocket Lab's Q3 revenue of $267.8 million, up 73% year over year, and record backlog of $3.57 billion restate the Nov 9 report. The new items are the guidance and the financing: management guided to a Q4 adjusted EBITDA loss wider than analysts expected, and the Pentagon committed $150 million in conditional loans to expand Neutron production, recovery operations and infrastructure. Neutron has $515 million in contracts but its first launch now targets 2027, a slip from the prior Q4 2026 target disclosed in the 10-Q. Five firms — Cantor Fitzgerald, Piper Sandler, Barclays, Needham and Morgan Stanley — cut price targets while keeping their ratings. The loan is modest next to the $4.7 billion of cash and securities on the balance sheet, so the wider Q4 loss and the Neutron delay carry more weight than the funding itself.
At the time of this announcement, RKLB was trading at $64.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $40.5B. The 52-week trading range was $37.57 to $151.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.